secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCURAY INC (ARAY)
CIK:        0001138723
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001193125-24-212084
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accuray CEO Suzanne Winter takes temporary medical leave; Sandeep Chalke named interim CEO
--------------------------------------------------------------------------------

- CEO Suzanne Winter taking temporary medical leave to treat a treatable form of cancer, effective September 3, 2024.
- Sandeep Chalke, Chief Commercial Officer, appointed interim CEO; compensation raised to $725k base salary and 100% bonus target.
- Board forms Executive Committee (Joseph Whitters and Anne Le Grand) to advise interim CEO during leave.
- Winter: 'I go into my treatment program extremely knowledgeable and able to advocate for the care I need.'

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138723/000119312524212084/0001193125-24-212084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138723/000119312524212084/d822972d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-212084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer